• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE AUTOGUARD; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE AUTOGUARD; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 381834
Device Problems Defective Component (2292); Defective Device (2588)
Patient Problems Extravasation (1842); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/03/2023
Event Type  malfunction  
Event Description
It was reported that bd insyte autogaurd needle went through catheter during insertion.The following information was provided by the initial reporter, translated from spanish to english."a puncture is performed in the left forearm to cannulate the patient with catheter number 20, and a knot is seen under the skin, the catheter is immediately removed when the catheter is extracted, and a rupture of the catheter is seen on one side of the needle".Additional information received.- was the reported incident noted before, during or after use on the patient?: ans: the report was made after use.- has there been any harm to the patient/health care professional (detail)?: ans: the patient presents mechanical phlebitis, without evolution and complication.- was there a need for medical and/or surgical intervention due to what happened (imaging tests, surgery, administration of medication, etc.)?: (detail) ans: no surgical intervention was needed.- was there exposure of blood/chemotherapy to mucous membranes (eyes, nose and mouth) or skin?: if yes, please state whether the exposure was the patient's or the practitioner's and what measures were taken.(detail).Ans: no exposure to fluids.- what medication was being administered?: ans: the medication was not administered, since in the first puncture the non-serious adverse event occurred.
 
Manufacturer Narrative
H.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
Additional information: 1) does the needle go through the catheter wall? ans - the needle went through the catheter wall at the end of the procedure.2) did the catheter and needle remain intact during the intravenous insertion process? ans - before inserting the catheter, the catheter was found to be intact upon inspection.3) did the reported event define a venous rupture ans - there was an extravasation of the vein.
 
Manufacturer Narrative
Investigation results: the complaint that the catheter was punctured was confirmed and the cause was likely associated with use.Two photographs were provided for investigation, which showed a 20ga insyte autoguard unit.One photo showed what appeared to be a breach in the catheter tubing near the tip.The catheter was likely damaged by the needle.As the damage was reportedly detected under the skin, the catheter was likely damaged during the insertion process.A review of the inspection records and quality/manufacturing controls for the implicated lot indicated no issues with the manufacturing process.This defect may occur during manufacturing.While the adapter is loaded onto the grip assembly, the adapter is placed to pre-seat tooling.Incorrect equipment settings may cause the catheter to get damaged or the needle to spear through the catheter tubing.A 100% vision system, challenge sample, and visual inspections per quality control plans are in place to mitigate the occurrence of this defect.Another possibility is that this occurred during client use.This defect may occur if the needle is advanced at the wrong angle or if the needle is moved up and down the catheter tubing while the tubing is in the vein.Ifu states to hold the needle assembly stationary after insertion and during catheter advance.This defect may also occur during tip adhesion break or needle cover removal.Normally if this defect was a result of manufacturing, the needle would be spearing through the catheter upon opening of the package, but since the complaint states that the defect occurred during use, this was most likely due to an application error.The complaint has been documented and will continue to be monitored as part of ongoing efforts to identify potential manufacturing related issues.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE AUTOGUARD
Type of Device
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key18023293
MDR Text Key326851128
Report Number1710034-2023-01233
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier00382903818341
UDI-Public(01)00382903818341
Combination Product (y/n)N
Reporter Country CodeCO
PMA/PMN Number
K952861
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/27/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number381834
Device Lot Number3010271
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/12/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/13/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-